Astrazeneca Pharma I Financial Results

For FY Latest, Astrazeneca Pharma I recorded Net Sales of ₹- crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

The Operating Profit of Astrazeneca Pharma I for FY Latest is ₹- crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

In FY Latest, Astrazeneca Pharma I posted a Profit Before Tax of ₹- croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

Astrazeneca Pharma I recorded a Net Profit of ₹- crores in FY Latest. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

The Face Value of Astrazeneca Pharma I shares is -.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

In FY Latest, the PAT Margin of Astrazeneca Pharma I is - %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Astrazeneca Pharma I using our TradeMobi App or Web Trading Platform.